Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers ...

Newer medications, such as Mounjaro and Wegovy, exhibit both more total weight lost and faster weight regain than older medications Montinique Monroe/Bloomberg via Getty A new analysis determined ...

as Wegovy but is FDA-approved to manage type 2 diabetes. It is sometimes prescribed off-label for weight loss. Ozempic costs can range from $900 to $1,800 per month. Mounjaro and Zepbound are two ...

Nearly 32% of Zepbound users ultimately lost at least a quarter of their body weight, compared with just 16% of Wegovy users ... the main ingredient in Mounjaro and Zepbound.

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants who took Zepbound lost more weight than those who took Wegovy.

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble ... the maker of the drug sold as Mounjaro and Zepbound. Novo Nordisk had a head start, winning approval to market ...

Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s Wegovy in the ... version of the drug, Mounjaro, is on track to ...

A new study led by Weill Cornell Medicine researchers reveals that tirzepatide (Mounjaro, Zepbound) helps people lose significantly more weight than semaglutide (Wegovy). The difference is ...

After 72 weeks of treatment, people taking Zepbound lost about 50 pounds, compared with 33 pounds for those taking Wegovy. The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight ...

Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients starting at $199 a month as easy access to cheaper copycats comes to an end. The one-time offer—available ...

Wegovy is approved for use in weight management. Another group uses the active ingredient tirzepatide. Mounjaro is approved to treat type 2 diabetes. Zepbound is approved for use in weight management.